Lorena Wiebes rounded off the UAE Tour Women with an impressive third stage victory, but it was the UAE Team ADQ’s Elisa ...
Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.
Planners have given the thumbs up to proposals to extend leisure facilities at a "popular and beautiful" coastal park on ...
Irruptions occur after large numbers of baby owls are hatched the year before, and then the following year, there’s not ...
For patients with BRAF V600E-mutant metastatic colorectal cancer (mCRC), encorafenib + cetuximab (EC) plus standard ch ...
SOUR LAKE, Texas — Classes across the Hardin-Jefferson school district will be starting late Tuesday morning due to a water ...
Pfizer Inc. (NYSE: PFE) today announced positive topline results from the progression-free survival (PFS) analysis of the Phase 3 BREAKWATER study of ...
BRAFTOVI's FDA Approval Sparks Hope for BRAF V600E-mutant Colorectal Cancer Patients and Sets Pfizer Up for Explosive Growth ...
Pfizer's Braftovi combination showed significant survival benefits in a Phase 3 study for BRAF V600E-mutant metastatic ...
Less than two months after an accelerated approval from the FDA, a drug combination featuring Pfizer’s Braftovi has turned in ...